Margaret Mueller to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Margaret Mueller has written about Xenograft Model Antitumor Assays.
Connection Strength
0.077
-
MMP inhibition blocks fibroblast-dependent skin cancer invasion, reduces vascularization and alters VEGF-A and PDGF-BB expression. Anticancer Res. 2010 Mar; 30(3):703-11.
Score: 0.019
-
Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Mol Cancer Ther. 2008 Jan; 7(1):101-9.
Score: 0.016
-
Volumetric high-frequency Doppler ultrasound enables the assessment of early antiangiogenic therapy effects on tumor xenografts in nude mice. Eur Radiol. 2008 Apr; 18(4):753-8.
Score: 0.016
-
Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101. Neoplasia. 2004 May-Jun; 6(3):213-23.
Score: 0.013
-
Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography. Cancer Res. 2003 Dec 01; 63(23):8264-70.
Score: 0.012